GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Additional Paid-In Capital

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Additional Paid-In Capital : ฿772.49 Mil(As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Additional Paid-In Capital?


JSP Pharmaceutical Manufacturing (Thailand) PCL's quarterly additional paid-in capital increased from Sep. 2023 (฿772.39 Mil) to Dec. 2023 (฿772.49 Mil) but then stayed the same from Dec. 2023 (฿772.49 Mil) to Mar. 2024 (฿772.49 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL's annual additional paid-in capital stayed the same from Dec. 2021 (฿733.46 Mil) to Dec. 2022 (฿733.46 Mil) but then increased from Dec. 2022 (฿733.46 Mil) to Dec. 2023 (฿772.49 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL Additional Paid-In Capital Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Additional Paid-In Capital Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
- 22.09 733.46 733.46 772.49

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 733.46 772.39 772.39 772.49 772.49

JSP Pharmaceutical Manufacturing (Thailand) PCL Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

JSP Pharmaceutical Manufacturing (Thailand) PCL Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Additional Paid-In Capital
Comparable Companies
BKK:DOD BKK:SSF BKK:NV BKK:SFP BKK:JDF BKK:LEE BKK:BIS BKK:TC BKK:SST BKK:CFRESH XSWX:NESN SHSE:603288 KHC GIS XPAR:BN SHSE:600887 SZSE:300999 HRL MKC K
Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
Website
https://www.jsppharma.com
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines